LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

Search

Omnicell Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

32.77 2.34

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

32.02

Max

32.79

Pagrindiniai rodikliai

By Trading Economics

Pajamos

13M

5.6M

Pardavimai

21M

291M

P/E

Sektoriaus vid.

66.18

35.724

Pelnas, tenkantis vienai akcijai

-0.151

Pelno marža

1.941

Darbuotojai

3,650

EBITDA

42M

30M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+30.06% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-10-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

162M

1.5B

Ankstesnė atidarymo kaina

30.43

Ankstesnė uždarymo kaina

32.77

Naujienos nuotaikos

By Acuity

50%

50%

167 / 371 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

Omnicell Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-09-02 23:07; UTC

Įsigijimai, susijungimai, perėmimai

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2025-09-02 22:10; UTC

Pagrindinės rinkos jėgos

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2025-09-02 21:47; UTC

Uždarbis

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2025-09-02 16:52; UTC

Pagrindinės rinkos jėgos

CleanCore Solutions Shares Drop After $175 Million Private Investment

2025-09-02 22:47; UTC

Rinkos pokalbiai

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2025-09-02 21:40; UTC

Įsigijimai, susijungimai, perėmimai

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2025-09-02 21:07; UTC

Uždarbis

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2025-09-02 21:07; UTC

Uždarbis

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2025-09-02 21:05; UTC

Uždarbis

Couche-Tard 1Q Rev $17.35B >ATD.T

2025-09-02 21:05; UTC

Uždarbis

Couche-Tard 1Q Adj EPS 78c >ATD.T

2025-09-02 21:05; UTC

Uždarbis

Couche-Tard 1Q EPS 82c >ATD.T

2025-09-02 21:05; UTC

Uždarbis

Couche-Tard 1Q Net $782.5M >ATD.T

2025-09-02 21:00; UTC

Rinkos pokalbiai

ESG Roundup: Market Talk

2025-09-02 20:53; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2025-09-02 20:51; UTC

Įsigijimai, susijungimai, perėmimai

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2025-09-02 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-09-02 20:27; UTC

Uždarbis

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2025-09-02 20:24; UTC

Įsigijimai, susijungimai, perėmimai

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2025-09-02 20:18; UTC

Įsigijimai, susijungimai, perėmimai

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2025-09-02 20:17; UTC

Įsigijimai, susijungimai, perėmimai

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2025-09-02 20:16; UTC

Įsigijimai, susijungimai, perėmimai

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2025-09-02 20:16; UTC

Įsigijimai, susijungimai, perėmimai

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2025-09-02 20:15; UTC

Įsigijimai, susijungimai, perėmimai

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2025-09-02 19:55; UTC

Uždarbis

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2025-09-02 19:50; UTC

Įsigijimai, susijungimai, perėmimai

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2025-09-02 19:09; UTC

Rinkos pokalbiai

Oil Futures Gain on Geopolitical Premium -- Market Talk

2025-09-02 19:00; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2025-09-02 18:12; UTC

Rinkos pokalbiai

Gold Pushes To New Record -- Market Talk

2025-09-02 17:04; UTC

Rinkos pokalbiai

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2025-09-02 16:57; UTC

Įsigijimai, susijungimai, perėmimai

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Omnicell Inc Prognozė

Kainos tikslas

By TipRanks

30.06% į viršų

12 mėnesių prognozė

Vidutinis 41.75 USD  30.06%

Aukščiausias 55 USD

Žemiausias 32 USD

Remiantis 6 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Omnicell Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

6 ratings

4

Pirkti

2

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

24.23 / 30.44Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

167 / 371 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.